Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2019) 66 OC5.10 | DOI: 10.1530/endoabs.66.OC5.10

BSPED2019 ORAL COMMUNICATIONS Oral Communications 5 (10 abstracts)

Review of neonatal cortisol evaluation between 2012–2018 in a single centre: trends, outcomes and associations

Taffy Makaya 1 , Satish Sarvasiddhi 1 , Elizabeth van Boxel 1 , Smrithi Menon 2 & Brian Shine 2


1Oxford Children’s Hospital, Oxford, UK; 2John Radcliffe Hospital, Oxford, UK


Background: Neonatal cortisol assessment is indicated in suspected adrenal insufficiency.

Aims/objectives: Review of neonatal cortisol assessment within our Trust over seven years, to analyse trends, indications, outcomes; and relationships between gestational age (GA), birth weight (BW) and cortisol assessment.

Methodology: From cortisol results on neonates (≤30 days age) between 2012–2018 (inclusive) we identified random/serial (‘screening cortisols’) versus cortisols done as part of Synathen tests. We analysed trends for testing. Further data collection was as follows:

• screening cortisols: Indication, number of tests, outcomes.

• Synacthen tests: Indication, type of test [short Synacthen test (SST) vs low dose Synacthen test (LDST)], results, short/long term outcomes, relationship to BW/GA.

Results: There were 412 cortisol tests over the 7 years, in 172 patients. Numbers were stable between 2012 and 2014, but between 2015/2016 and 2017/2018 there was a 230% increase in cortisol; and 430% rise in Syacnthen tests. This was despite stable admission rates: 1997 patients over 2015/2016 and 1916 in 2017/2018. Further results: Table 1.

There was no significant relationship between premature versus term deliveries and abnormal Synacthen tests (P=0.32); or between BW (i.e. SGA vs AGA) and abnormal Synacthen tests (P=0.67).

Table 1 Screening cortisol versus Synacthen tests.
Screening cortisolsSynacthen tests
Number of patients Split143 (=83%) 66.4% (n=95/143): single screening cortisol test 33.6% (n=48/143): ³2 screening cortisol tests29 (=17%) 72.4% (n=21/29) were SSTs 27.6% (n=8/29) were LDSTs
Top 3 indications:Hypoglycaemia(35.6%), ambiguous genitalia(16%), conjugated jaundice(9%)Hypoglycaemia(44.8%), ambiguous genitalia(6.9%) and hyponatremia(6.9%)
Outcomes:Only ONE patient was started on treatment based on just screening results. Subsequent SST confirmed adrenal insufficiency.38% of the initial Synacthen tests were abnormal (n=11/29). Of these only 36% (n=4/11) remained on treatment after age of 2 years: Dx=2x Hypopitutarism + 1x Hypoglycaemia, SGA and maternal pre-eclampsia +1 Preterm (repeat SST pending).

Summary/conclusions: Despite an exponential increase in cortisol assessments, 91% of testing indications were appropriate. Initial pick-up of adrenal insufficiency was low (6%). Subsequent reassessment of adrenal function is imperative as 64% of these results were transient. There were no associations between BW or GA and abnormal Syancthen results.

Volume 66

47th Meeting of the British Society for Paediatric Endocrinology and Diabetes

Cardiff, UK
27 Nov 2019 - 29 Nov 2019

British Society for Paediatric Endocrinology and Diabetes 

Browse other volumes

Article tools

My recent searches

No recent searches.